Drug Companies Target India For R&D Under New Patent Regime

Law360, New York (September 21, 2004, 12:00 AM EDT) -- International pharmaceutical companies are ramping up their investments in India in anticipation of the introduction of product patents in the country in 2005, according to local reports.

At the same time, many global drug makers are bolstering their legal teams to prepare for possible legal battles with local generics makers, the Economic Times of India reported. Most large drug originators expect legal cost to continue to rise until at least 2008, when many of the legal issues arising from the new patent regime should be resolved...
To view the full article, register now.